Brandes Investment Partners’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Buy |
271,322
+29,073
| +12% | +$1.65M | 0.14% | 111 |
|
|
2025
Q1 | $13.6M | Buy |
242,249
+79,280
| +49% | +$4.44M | 0.14% | 110 |
|
|
2024
Q4 | $10M | Buy |
162,969
+24,604
| +18% | +$1.51M | 0.11% | 116 |
|
|
2024
Q3 | $9.26M | Buy |
138,365
+21,841
| +19% | +$1.46M | 0.1% | 113 |
|
|
2024
Q2 | $7.79M | Buy |
116,524
+46,427
| +66% | +$3.1M | 0.1% | 110 |
|
|
2024
Q1 | $4.98M | Buy |
70,097
+37,272
| +114% | +$2.65M | 0.06% | 115 |
|
|
2023
Q4 | $2.76M | Buy |
32,825
+5,746
| +21% | +$484K | 0.04% | 129 |
|
|
2023
Q3 | $2.33M | Buy |
27,079
+3,799
| +16% | +$327K | 0.05% | 123 |
|
|
2023
Q2 | $2.17M | Buy |
23,280
+1,775
| +8% | +$165K | 0.04% | 123 |
|
|
2023
Q1 | $2.04M | Buy |
+21,505
| New | +$2.04M | 0.04% | 124 |
|
|
2022
Q4 | – | Sell |
-7,858
| Closed | -$670K | – | 159 |
|
|
2022
Q3 | $670K | Sell |
7,858
-68
| -0.9% | -$5.8K | 0.02% | 143 |
|
|
2022
Q2 | $681K | Buy |
+7,926
| New | +$681K | 0.02% | 143 |
|
|
2021
Q4 | – | Sell |
-9,226
| Closed | -$857K | – | 170 |
|
|
2021
Q3 | $857K | Sell |
9,226
-453
| -5% | -$42.1K | 0.02% | 131 |
|
|
2021
Q2 | $823K | Buy |
9,679
+4,317
| +81% | +$367K | 0.02% | 129 |
|
|
2021
Q1 | $465K | Buy |
+5,362
| New | +$465K | 0.01% | 137 |
|
|
2019
Q3 | – | Sell |
-2,468
| Closed | -$236K | – | 149 |
|
|
2019
Q2 | $236K | Buy |
+2,468
| New | +$236K | 0.01% | 134 |
|
|
2017
Q4 | – | Sell |
-39,022
| Closed | -$2.87M | – | 167 |
|
|
2017
Q3 | $2.87M | Sell |
39,022
-108
| -0.3% | -$7.94K | 0.06% | 106 |
|
|
2017
Q2 | $2.83M | Buy |
+39,130
| New | +$2.83M | 0.04% | 105 |
|
|
2016
Q2 | – | Sell |
-9,570
| Closed | -$599K | – | 203 |
|
|
2016
Q1 | $599K | Sell |
9,570
-4,623
| -33% | -$289K | 0.01% | 131 |
|
|
2015
Q4 | $831K | Buy |
+14,193
| New | +$831K | 0.01% | 122 |
|